MAPK3 and prostate neoplasm: In fact, elevated levels of the subfamily of extracellular signal-regulated kinases 1 and 2 (ERK-1/2) could be observed in advanced prostate tumours (Gioeli et al, 1999; Price et al, 1999; Uzgare et al, 2003).